TM Editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.
Company: Zhejiang Hisun Pharmaceutical Company Limited
Bloomberg ticker: 600267 SH
Market cap: US$1,424m
Background: Zhejiang Hisun Pharmaceutical Company Limited is a Chinese company, principally engaged in the research and development, manufacture and distribution of specialty bulk pharmaceutical chemicals and preparation products.
World Class Benchmarking of Zhejiang Hisun Pharmaceutical
(Click on image to enlarge)
- Profitable Growth rank of 10 was down compared to the prior period’s 9th rank
- This is poor performance compared to 380 large Health Care companies worldwide
- Profitability rank of 9 was better than its Growth rank of 10
- Profitability rank of 9 was the same compared to the prior period’s 9th rank
- This is poor performance compared to peers
- Growth rank of 10 was the same compared to the prior period’s 10th rank
- This is poor performance compared to peers
More By This Author:
Asian Stock - Hengtong Optic-ElectricAsian Stock: International Container Terminal Services
Asian Stock - China Communications Services Corporation
Comments
Log in or sign up to join the conversation.